Search for: "Smith v. Flynn" Results 41 - 60 of 76
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2023, 9:00 pm by Michael C. Dorf
Congress did just that in the Ethics in Government Act, but SCOTUS upheld the independent counsel in Morrison v. [read post]
6 Nov 2009, 5:09 pm
Law Firm Fined for Filing Papers with Social Security Numbers - Minneapolis lawyer V. [read post]
5 Apr 2007, 8:16 am
Dr Denkowski found thatRobert Smith had mental retardation, and an IQ of 63. [read post]
15 Jan 2012, 8:27 pm by Simon Gibbs
The argument put forward by some claimant representatives was that explained in Smiths Dock v Edwards [2004] EWHC 1116 QB: “Mr Morgan QC submitted that because most wholly unsuccessful cases reach trial whilst most successful cases settle before trial, there is a disequilibrium that should result in higher success fees. [read post]
26 Jan 2011, 2:10 am by Randall Reese
Flynn in Support of Debtors' Chapter 11 Petitions and First Day Motions Filed By Summit Business Media Holding CompanyMotion of Debtors for Interim and Final Orders (I) Authorizing Post-Petition Secured Financing Pursuant to Sections 105, 361, 362, 364(c)(1), 364(c)(2), 364(d)(1), 364(e) and 503(b) of the Bankruptcy Code; (II) Authorizing the Debtors to Use Cash Collateral; (III) Providing Adequate Protection to the Existing First Lien Secured Parties and Existing Second Lien Lenders… [read post]
21 Jul 2008, 6:24 am
[She sent them to] Sergeant James Flynn. . . . [read post]
1 Aug 2011, 8:23 am by Graeme Hall
Smith & Ors, R. v (Rev 1) [2011] EWCA Crim 1772 (19 July 2011): Court of Appeal: Blanket internet bans for Sexual Offences Prevention Orders always disproportionate; court gives general guidance. [read post]
7 Feb 2020, 12:43 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]